Anna Kondic
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Biosimilars and Bioanalytical Methods
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 6
- Pancreatic and Hepatic Oncology Research 2
- Colorectal Cancer Treatments and Studies 2
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Rik de Greef (7 shared papers)Julie A. Stone (5 shared papers)Malidi Ahamadi (6 shared papers)Tomoko Freshwater (6 shared papers)Dinesh de Alwis (2 shared papers)Claire H. Li (1 shared paper)David C. Turner (4 shared papers)Kapil Mayawala (3 shared papers)
- Journals
- Journal of Pharmacokinetics and Pharmacodynamics (4 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)Journal for ImmunoTherapy of Cancer (2 papers)Journal of Clinical Oncology (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- United StatesSwedenFrance
In The Last Decade
Anna Kondic
16 papers receiving 739 citations
Peers
Comparison fields: 5 of 65
- Oncology 480
- Immunology 171
- Genetics 42
- Statistics and Probability 35
- Cancer Research 53
Countries citing papers authored by Anna Kondic
This map shows the geographic impact of Anna Kondic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kondic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kondic more than expected).
Fields of papers citing papers by Anna Kondic
This network shows the impact of papers produced by Anna Kondic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kondic. The network helps show where Anna Kondic may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Kondic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 185 | |
| 2 | 2018 | 160 | |
| 3 | 2016 | 122 | |
| 4 | 2017 | 116 | |
| 5 | 2014 | 54 | |
| 6 | 2019 | 46 | |
| 7 | 2016 | 22 | |
| 8 | 2016 | 10 | |
| 9 | 2025 | 8 | |
| 10 | 2015 | 7 | |
| 11 | 2022 | 6 | |
| 12 | 2020 | 5 | |
| 13 | 2015 | 5 | |
| 14 | 2015 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Anna Kondic
Anna Kondic is a scholar working on Oncology, Immunology, Statistics and Probability, Pulmonary and Respiratory Medicine and Cancer Research, having authored 21 papers that have together received 750 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (5 papers), Statistical Methods in Clinical Trials (5 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (480 citations), Immunology (171 citations), Genetics (42 citations), Statistics and Probability (35 citations) and Cancer Research (53 citations). Anna Kondic has collaborated with scholars based in United States, Sweden and France. Frequent co-authors include Rik de Greef, Julie A. Stone, Malidi Ahamadi, Tomoko Freshwater, Dinesh de Alwis, Claire H. Li, David C. Turner, Kapil Mayawala, Jeroen Elassaiss‐Schaap and Lokesh Jain. Their work appears in journals such as Journal of Pharmacokinetics and Pharmacodynamics, CPT Pharmacometrics & Systems Pharmacology, Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.